Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A curated listing of global health funding opportunities.

ABOUT

Wellcome is funding the establishment of five global evidence synthesis infrastructure hubs to strengthen timelyrelevant and affordable evidence synthesis in low- and middle-income countries (LMICs). Hubs will use AI-enabled methods to support health research and policy and must align with at least one priority area (Climate and Health, Infectious Disease, Mental Health or Discovery Research) and one policy sector, such as food systems, humanitarian assistance, economic growth, peace and effective institutions, or social protection.

AMOUNT

£1.5 million-£1.9 million per hub over 3-5 years 

ELIGIBILITY

Lead applicants must be based at eligible organisations in LMICs (excluding mainland China)

Find out more and apply

To honour Paul Farmer's memory, the McGill School of Population and Global Health has created a lectureship and award that will be given, on an annual basis, to an individual who models and demonstrates Paul’s vision of a ‘preferential option for the poor’ to achieve equity in health. In particular, the award will be used to honour individuals (or couples) working in under-served communities whose work is often not recognized or made visible. 

Deadline

11:59 PM EDT; 12 June 2026

This postdoctoral fellowship supports early to mid‑career global health researchers to build leadership and research expertise. Funded through Official Development Assistance (ODA), it supports applied research that strengthens health systems and improves outcomes for the poorest and most vulnerable populations in South Asia and sub‑Saharan Africa, including maternal, newborn, child and adolescent health. Priority areas include epidemic‑ and pandemic‑prone infectious diseases, pandemic preparedness, antimicrobial resistance (AMR), infectious diseases of poverty, and the links between undernutrition and infection.  

Funding amount: Up to £750,000 over 2 to 5 years.

Find out more and apply

ABOUT

The CAP Foundation’s Global Pathology Development Grant supports international projects that strengthen and expand pathology services in low-resourced settings. Funding is aimed at sustainable, high-impact initiatives across education and training, patient care, laboratory quality, and diagnostic technologies. 

AMOUNT

FundingUp to USD 10,000 

ELIGIBILITY

Open to pathologists and laboratory professionals seeking to develop or expand pathology services in low-resource settings globally. Projects must demonstrate clear collaboration with a partner institution in the country where the work will take place. The scheme is not restricted to US citizens; international applicants are eligible in line with the foundation’s requirements.

CAP membership is preferred but not mandatory.

Find out more and apply

About

The Discovery Research programme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.  

criteria 

  • Funding amount: salary and up to £400,000 for research expenses. 
  • Funding duration: Usually 5 years (but may be less for some disciplines) 

 

 

Find out more and apply

 

About

This scheme supports academically led translational research to progress innovative health interventions towards patient benefit or commercialisation. Funding is available for projects at any stagefrom early development through pre-clinical work to early-phase clinical trialsacross all disease areas. The scheme supports a wide range of outputs, including therapeutics, devices, diagnostics, digital health, and other interventions that improve health or accelerate intervention development.

Criteria

  • No fixed funding limit (80% full economics costs covered)
  • The call is expected to open 2 July 2026, with multiple annual deadlines (March, July, November).
  • Criteria: employment at a research organisation eligible for MRC funding. 

Apply to the MRC: Developmental Pathway Funding scheme